Santillán-Doherty P, del Campo GLAM

Idioma: Español
Referencias bibliográficas: 21
Paginas: 75-77
Archivo PDF: 31.89 Kb.

FRAGMENTO

El término timoma se refiere a una neoplasia poco común derivada de las células epiteliales del timo, que representa alrededor del 30% de las masas de mediastino anterior en adultos.
Las neoplasias epiteliales de timo se presentan en casi todas las edades (rango de 7 a 89 años), presentando un pico de incidencia entre los 55 y 65 años de edad. Son responsables de menos del 1% de los cánceres en el adulto, con una incidencia de 1 a 5 casos por millón de habitantes al año. Sin embargo, representan un problema clínico en el sentido de la sospecha, la evaluación diagnóstica y las decisiones terapéuticas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kondo K. Optimal therapy for thymoma. J Med Invest 2008; 55: 17-28.

2. Casey E, Kiel P, Pharm D, Loehrer P. Clinical management of thymoma patients. Hematol Oncol Clin N Am 2008; 22: 457-473.

3. Morrissey B, Adams H, Gibbs AR, et al. Percutaneous needle biopsy of the mediastinum: review of 94 procedures. Thorax 1993; 48: 632–7.

4. Rosado-de-Christenson M, Strollo D, Marom E. Hematol Oncol Clin N Am 2008; 22: 409-431.

5. Leyvraz S, Henle W, Chahinian AP, et al. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med 1985; 312: 1296–9.

6. Rosado-de-Chrstenson M, Strollo D, Marom E. Imaging of thymic epithelial neoplasms. Hematol Oncol Clin N Am 2008; 22: 409-431.

7. Kaiser L. Surgical treatment of thymic epithelial neoplasms. Hematol Oncol Clin N Am 2008; 22: 475-488.

8. Rea F, Marulli G, Girardi R, Bortolotti L, Favaretto A, Galligioni A, Sartori F. Long-term survival and prognostic factors in thymic epithelial tumours. Eur J Cardiothorac Surg 2004; 26(2): 412-8.

9. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumours of the lung, pleura, thymus and heart. In: WHO classification of tumours. 2nd ed. IARC Press, Lyon, 2004: 145-197.

10. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Torac Surg 2006; 81: 2328-34.

11. Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, et al. WHO Histologic Classification is a Prognostic Indicator in Thymoma. Ann Thorac Surg 2004; 77: 1183-8.

12. Chen G, Marx A, Chen W, Jiang Y, Puppe B, Stroebel P. New WHO histologic classification predicts prognosis of thymic epithelial tumors. A clinicopathologic study of 200 thymoma cases from China. Cancer 2002; 95: 420–29.

13. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485–92.

14. Kim D, Yang W, Choi S, Kim K, Chung K. Prognostic and clinical relevance of the World Health Organization Schema for the classification of thymic epithelial tumors. A clinicopathologic study of 108 patients and literature review. Chest 2005; 127: 755-61.

15. Kondo K, Monden Y. Therapy for Thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003; 76: 878-85.

16. Gamondes JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: Factors influencing survival. Eur J Cardiothorac Surg 1991; 5: 124–131.

17. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996; 112: 376–81.

18. Okumura M, Hiroyuki S, Masato M, Masayoshi I, et al. Clinical and pathological aspects of thymic epithelial tumors. Gen Thorac Cardiovasc Surg 2008; 56: 10-16.

19. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: A study of 146 consecutive tumors. Am J Surg Pathol 2001; 25: 103–10.

20. Wick M. Prognostic factors for thymic epithelial neoplasms, with emphasis on tumor staging. Hematol Oncol Clin N Am 2008; 22: 527–542.

21. Shin DM, Walsh GL, Komaki R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 1998; 129: 100–4.